CB Insights names ER as key China pharma investor
Eight Roads is included in CB Insights' ranking of China Innovative Drug Early Stage Investors.

Eight Roads has a strong credential in healthcare investment. It was the founding investor of Innovent Biologics, Hua Medicine, Adagene and Citrine Medicine. It also invested in Semma Therapeutics, Shouti and Insilico Medicine.